GDP Audits : Weak points when conducting GDP Audit based on inspections
|
|
- Winifred Powers
- 6 years ago
- Views:
Transcription
1 GDP Audits : Weak points when conducting GDP Audit based on inspections s COOL SUPPLY System & Solutions 2017 Webinar 15 February 2017 Riekert Bruinink Dutch Healthcare Inspectorate
2 2 Titel van presentatie datum van presentatie
3 AGENDA 1. GDP inspection practice 2. Review of GDP and GDP/GMP inspections - Quality management issues - Responsible Person /training - Temperature management storage / returns - Qualification / outsourcing / transportation 3
4 1. Introduction EU GDP Guidelines Publication new EU GDP guide: 7 th March 2013 Implementation period : 6 months (until 8 September 2013) Publication new version EU GDP Guidelines ( corrections text and translation errors) 4
5 1.GDP Inspection process in general Frequency of GDP inspections Planning (can be risk based) How many and which topics are inspected? It isn t possible to inspect everything Announced / unannounced inspections How long? How many inspectors? 5 Titel van presentatie datum van presentatie
6 1. GDP Inspection process Announcement inspection by a letter Confirmation Request for some documents (SMF/ QMS/Products) inspection - introduction - developments / changes since last inspection - organization / position RP - follow-up previous inspection 6 Titel van presentatie datum van presentatie
7 1. GDP inspection process making programme walking around : inspecting facilities (e.g. entrance, routing of goods, receive,storage /temperature / dispatch ) verification registrations / documents summing up ( critical /major /minor deficiencies) 7 Titel van presentatie datum van presentatie
8 1. GDP inspection process Inspection report Reply of the company with planned/ performed corrections Documented reply for the major remarks Review by the inspector(s) Closing inspection 8 Titel van presentatie datum van presentatie
9 1. Results of an GDP inspection Critical deficiency : significant departure/ risk for the patient Major deficiency : which indicates a (system)failure to carry out satisfactory procedures a combination of several other deficiencies, Minor deficiency : A deficiency, which cannot be classified as either critical or major, but which indicates a departure from GDP. 9 Titel van presentatie datum van presentatie
10 1. Results of an GDP inspection Not compliant with GDP - Critical shortcoming - Majors remarks (4>) - Warning letter / Stop activities? - Re inspection within a year Compliant with GDP after a positive PVA - less then 3/4 majors Compliant with GDP - zero remarks / minor shortcomings 10 Titel van presentatie datum van presentatie
11 1. Results of an GDP inspection GDP certificate after each positive GDP inspection of a wholesaler Given by Healthcare Authorities There are other GDP Certificates (commercial) 11
12 2. Results of GDP inspections Method 35 inspections during the first 6 months of 2014 what kind of companies? - wholesalers with full assortment - parallel wholesalers - logistic providers with warehousing - pharmaceutical wholesalers / exporters - manufacturers with wholesale activities 12
13 2. Results of 35 GDP inspections / topics Quality Management issues (1) Training / Responsible Person (2) Temperature management storage (3) Qualification suppliers / customers (5) Returns / Outsourcing (6/7) Self-inspection system (8) Transportation issues (9) 13
14 2. Management review Chapter 1 : A management review should be made based on analyses of the Quality registrations ; discussion with the management and proposal improvements. 14
15 2. Results of GDP inspections Results : Management review available : 58 %. SOP management review : 52 % Remarks : Management not always involved Not all quality information used Follow up improvements 15
16 2. Riskanalyses Chapter 1 : Risk analysis procedure and analysis of most important risks ;planned measures to reduce risks 16
17 2. Results of GDP inspections Results : Risk analyses performed : 48 % SOP risk analyses : 40 % Unknown : 10 % Remarks First risk analyses,not always based on method Discussion in team 17
18 2. Personnel,training, Responsibel Person Chapter 2 : GDP System for planning and registration GDP training for all involved personnel; training based on new GDP Guidelines; job description RP 18
19 2. Results of GDP inspections Results : System for GDP training : 81 %. Training new GDP Guideline : 54 % Description tasks RP : 69 % Remarks : 30 % of the RP s didn t follow new GDP training Some companies had planned new GDP training 19
20 2. Temperature management storage area Chapter 3 : monitoring, registration and control temperature storage area; alarm and follow-up ; mapping during summer and winter 20
21 2. Results of GDP inspections Results : Monitoring, registration, control : 94 %. Weak system : 18% Temperature mapping : 62 % Temperature mapping (S and W) : 27% Alarm system : 65 % Follow-up alarm :50 % Remarks : Sometimes only one device Sometimes temperature excursions without actions ; alarms on temperature monitoring device. 21
22 2. Qualification of suppliers (customers) Chapter 5 : Qualification of suppliers /customers based on authorization and other items ( i.e.questionnaire about quality status ) SOP should been in place. 22
23 2. Results of GDP inspections Results : Based on authorization : 97 %. Remarks : 35 % Based on questionnaire : 24 % Remarks : Licenses not always controlled and up to date Delivering to unauthorized clients 2 times. Check your performance yearly! 23
24 2. Results of GDP inspections Chapter 6 : System for handling and judging returned goods ; SOP available; based on new GDP Guidelines Results : System available /SOP : 90 %. Based on new GDP Guideline : 20 % Remarks : Responsible Person not always involved Criteria GDP Guideline not followed 24
25 2. Self-inspections Chapter 8 : Self-inspections should be planned and performed periodically; SOP 25
26 2. Results of GDP inspections (Self-inspections) Results : Operational system : 72 %. SOP : 90 % Follow up : 45% Remarks : Sometimes frequency too low. Don t forget QA. External audits are not the same Follow up by CAPA s 26
27 2. Transportation * Chapter 9 : Transportation outsourced,audits performed and contracts (QA,TA) available. 27
28 2. Results of GDP inspections (transportation) Results : Transportation outsourced : 77 %. Contracts available : 84 % Audits performed : 64 % Remarks : Use of sub-contracters with permission. Contracts not always based on new GDP Guideline Not always enough GDP appointments. 28
29 2. Finally The results of the first GDP inspections are reasonable Around 20 % was not compliant Weak points are : - Management review / risk analyses ( around 50%) - Handling returned goods - Qualification suppliers based on quality information. - Temperature mapping storage area - Follow up alarms, temperature excursions selfispections - Temperature mapping There is space for improvement! 29
30 30 Titel van presentatie datum van presentatie
MHRA GDP Symposium. Novotel London West, London 8 & 10 December #GMDPevents
MHRA GDP Symposium Novotel London West, London 8 & 10 December 2015 Deficiencies in GDP Phil Neale, GDP Operations Manager Tony Orme, GDP Senior Inspector. Finding deficiencies in GDP is not only for those
More informationOverview SFLGDP1. Develop, implement and maintain a quality system to control the distribution of medicinal products
Overview This standard is about developing, implementing and maintaining a quality system to control the. You will be responsible for developing the quality system and confirming colleagues understand
More informationEvaluation of Counterfeit Cases Impact of FMD & GDPs. Lorraine Nolan Healthcare Products Distribution Manager
Evaluation of Counterfeit Cases Impact of FMD & GDPs Wholesale Distribution Information Day, 28th September 2012 Lorraine Nolan Healthcare Products Distribution Manager Slide 1 Contents 1. Review of UK
More informationUNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products
UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products UNICEF Industry Consultation with Manufacturers and Suppliers of Finished Pharmaceutical Products 29 th 30 th September
More informationOverview SFLGDP1- HP Develop, implement and maintain a quality system to control the distribution of medicinal products
- HP97 04 Overview What this standard is about This standard is about developing, implementing and maintaining a quality system to control the. You will be responsible for developing the quality system
More informationNew GDP Guidelines - Implementation
New GDP Guidelines - Implementation Alfred Hunt, Inspector Wholesale Distribution Conference 11 th November 2014 New GDP Guidelines 2013/C 63/01-8 th September 2013 2013/C 343/01-5 th November 2013 2 1994
More informationFeedback from Inspection Programme
Feedback from Inspection Programme Wholesale Distribution Conference 8 th February 2017 Darren Scully Health Products Distribution Manager Wholesale distribution overview wholesale distribution procure
More informationWebinar Expert Module 3: GMP Inspections Dupont
Webinar Expert Module 3: GMP Inspections Dupont 26 January & 9 February 2018 GOP-Innovations your Partner for Practical Training and e-learning Milenko Pavičić Pharmaceutical microbiologist, trainer, coach
More informationHealthcare Good Distribution Practice (GDP)
Healthcare Good Distribution Practice (GDP) 10 March 2018 Copyright silverbacklogistics.com. All rights reserved The place to go for free supply chain advice 1 The role of the MHRA Ensuring that medicines
More informationWholesaling & Distribution & the GMPs
Wholesaling & Distribution & the GMPs Presented by Bryan Wright 11 th July 2016 Overview Wholesaling & distribution of Medicines (FPs) in the EU New EU GDP Guidelines Expectations How complicated can the
More informationWholesaling & Distribution & the GMPs
Wholesaling & Distribution & the GMPs Presented by Bryan Wright 11 th July 2016 Overview Wholesaling & distribution of Medicines (FPs) in the EU New EU GDP Guidelines Expectations How complicated can the
More informationMHRA GDP Symposium. Novotel London West, London 8 & 10 December #GMDPevents
MHRA GDP Symposium Novotel London West, London 8 & 10 December 2015 Complex Business Models - Outsourced Activities Presented by: Jacqueline Masayi, GDP Inspector Background Increased complexities of the
More informationManagement System Hilton Olympia, London 13 th February 2013
14. Building A Robust Quality Management System Hilton Olympia, London 13 th February 2013 Calcott Consulting consultant to the pharmaceutical & biotechnology industry Presenter s note Please note, the
More informationUNICEF Quality Assurance in the procurement of medicines
UNICEF Quality Assurance in the procurement of medicines Peter S. Jakobsen 30 October 2006 Quality Assurance Centre SUPPLY DIVISION Today s presentation addresses 3 questions: How is UNICEF involved in
More informationTopics summarised in this presentation are: method for defining quality level you want meaning of external controls quality assurance activities
Topics summarised in this presentation are: method for defining quality level you want meaning of external controls quality assurance activities audit, audit report and CAPA 1. QUALITY must be guaranteed,
More informationLogistic Provider Qualification: prerequisites and SLA
Logistic Provider Qualification: prerequisites and SLA Summary of the Content Benchmarking comparable providers and services to cope with product and market requirements Pre-qualification Activities Operational
More informationOverview sulla nuova guideline GDP
AFTI 09 febbraio 2012 Overview sulla nuova guideline GDP Fabio Dotto Ispettorato Regionale Medicamenti Svizzera del Sud 1 113 GDP Guidelines GDP of Medicinal Products for Human Use Public consultation
More informationBy Christoph Frick and Nicola Spiggelkötter. Creating a Master Plan for Drug Warehousing, Transportation and Distribution
By Christoph Frick and Nicola Spiggelkötter Creating a Master Plan for Drug Warehousing, Transportation and Distribution ISBN: 978-3-943267-93-8 Where a product trademark, registration mark, or other protected
More informationThe list of certified companies may be consulted at ECOCERT Head office during regular office hours.
P a g e 1 The list of certified companies may be consulted at ECOCERT Head office during regular office hours. ECOCERT holds at your disposal an "information for certification GLOBALGAP" questionnaire,
More informationCompliance with the GMP Standard in the International Level
Compliance with the GMP Standard in the International Level 27 th August 2018 Chandrashekar Ranga Deputy Drugs Controller (India) CDSCO (HQ) 1 Outline Provisions under the Drugs and Cosmetics Act, 1940
More informationPrequalification Team WHO PUBLIC INSPECTION REPORT (WHOPIR) Active Pharmaceutical Ingredient (API) Manufacturer
Prequalification Team WHO PUBLIC INSPECTION REPORT (WHOPIR) Active Pharmaceutical Ingredient (API) Manufacturer PART 1: GENERAL INFORMATION Name of Manufacturer Calyx Chemicals & Pharmaceuticals Ltd Unit:
More informationV Final report. Final Report GMP inspection Hospira Enterprises B.V. Almere January 15, Utrecht, 2015
1003920 2015-1167072 Final report Final Report GMP inspection Hospira Enterprises B.. Almere January 15, 2015 Utrecht, 2015 1003920 2015-1167072 Final report Report Reference no.: ame of product(s) and
More informationAgency and Internal Labeling
Agency and Internal Labeling Audits Joseph McMillian, MA Heartland Compliance Services LLC Internal Labeling Audits The views and opinions expressed in the following PowerPoint slides are those of the
More informationSupplier Oversight PQRI. September Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan
Supplier Oversight September 2014 PQRI Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan Agenda Mylan Background Setting the Stage with a Scenario Current State Thinking Supplier Qualification
More informationPharmaceutical Good Manufacturing Practice. Contents are subject to change. For the latest updates visit
Pharmaceutical Good Manufacturing Practice Page 1 of 6 Why Attend A robust quality system that meets the requirements of pharmaceutical regulators is an essential element of every good pharmaceutical manufacturing
More informationUNICEF Quality Assurance in the procurement of medicines
UNICEF Quality Assurance in the procurement of medicines Peter S. Jakobsen October 2008 Quality Assurance Centre SUPPLY DIVISION 2 Today s presentation addresses 3 questions: How do UNICEF manage quality
More informationThe APIC Audit Programme Version 5, July 2017
The APIC Audit Programme Version 5, July 2017 Table of contents 1 General 2. APIC Audit Programme 3 The Auditors 3.1 Educational Background and Experience 3.2 Auditor Training Courses for Certification
More informationGLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE QA.APP.GEN-52 Laboratory Commodities and Consumables: Supplier Technical Questionnaire
GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE Laboratory Commodities and Consumables: Supplier Technical Questionnaire This questionnaire is used to collect information from offerors of Laboratory Commodities
More informationCompounding Pharmacies and the Contract Testing Lab
Compounding Pharmacies and the Contract Testing Lab Scott Sutton, Ph.D. scott.sutton@microbiol.org 1 Disclaimer I am making this presentation as an independent agent I am not making this presentation as
More informationQUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION
PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PS/W 1/2011 2 Annexes 22 July 2011 QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION PIC/S 2011 Reproduction
More informationMDSAP AUDIT PROCESS. A Manufacturer s Perspective. Connie Hoy EVP Regulatory Affairs Cynosure, Inc.
MDSAP AUDIT PROCESS A Manufacturer s Perspective Connie Hoy EVP Regulatory Affairs Cynosure, Inc. Cynosure Located in Westford, MA Largest manufacturer of Medical Lasers Second location in Hicksville,
More informationPreparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014
Preparing Your Aseptic Processing Facility for an FDA Inspection Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Agenda Regulatory Requirements Establishing your Approach Aseptic Controls
More informationPROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT
August 2010 RESTRICTED PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT Please address any comments on this draft guideline
More informationQuality Risk Management (QRM) of active pharmaceutical ingredients during transportation by using FMEA tools and methodology
PharmaTutor PRINT ISSN: 294-6679 E-ISSN: 247-788 2 Quality Risk Management (QRM) of active pharmaceutical ingredients during transportation by using FMEA tools and methodology Upendra Kumar Singh*, Sammer
More informationGUIDANCE FOR THE PREPARATION OF GOOD CLINICAL PRACTICE INSPECTION REPORTS
EUROPEAN COMMISSION ENTERPRISE and INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals GUIDANCE DOCUMENTS CONTAINING THE COMMON PROVISIONS ON THE CONDUCT OF GCP INSPECTIONS BY COMPETENT AUTHORITIES
More informationCSV Inspection Readiness through Effective Document Control. Eileen Cortes April 27, 2017
CSV Inspection Readiness through Effective Document Control Eileen Cortes April 27, 2017 Agenda Background CSV Readiness CSV and Change Management Process Inspection Readiness Do s and Don ts Inspection
More informationSupersedes Division Name Revision No. 0 Export Division Page No. 1 of 9
Page No. 1 of 9 Control Status 1.0 Purpose To lay down a procedure for conducting GMP inspection and report writing for issue of Written Confirmation for for medicinal products for human. 2.0 Scope This
More informationPharmacovigilance Inspection Metrics Report
Pharmacovigilance Inspection Metrics Report April 2016 - March 2017 1. Introduction During the period 01 April 2016 to 31 March 2017, the GPvP Inspectorate conducted 36 inspections of marketing authorisation
More informationHow does the GDP guidelines impacted DGF on Local and Global level. 25 june 2013
How does the GDP guidelines impacted DGF on Local and Global level. 25 june 2013 Overview Introduction Who is DHL? What is GDP? DGF services Global approach DGF services Belgium 2 Introduction Elledin
More informationGuide to Wholesaling and Brokering of Medicinal Products for Human Use in Ireland
Guide to Wholesaling and Brokering of Medicinal Products for Human Use in Ireland IA-G0008-5 17 JUNE 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance
More informationQuality System Regulation (QSR) Training
Quality System Regulation (QSR) Training Or How to Ensure Development, Production and Sale of Safe, Effective, Consistent Product FDLI February 2003 Overview QSR History, Purpose and Scope Changes from
More informationUnofficial Translation
Unofficial Translation Manual of Auditing and Certification of Energy Management for Energy Auditor Manual of Auditing and Certification of Energy Management for Energy Auditor Department of Alternative
More informationPharma and Logistic Service Providers (LSP) Synergies and opportunities GDP, NEW EUROPEAN DIRECTIVES
Pharma and Logistic Service Providers (LSP) Synergies and opportunities GDP, NEW EUROPEAN DIRECTIVES DB Schenker Healthcare Conference Europe April 17-18 th 2012 J. BERLO Industrial Pharmacist/Clin. Biol.
More informationCAPA Management: Best Practices and FDA QSR Mandate WHITE PAPER. ComplianceQuest In-Depth Analysis and Review
CAPA Management: Best Practices and FDA QSR Mandate WHITE PAPER ComplianceQuest In-Depth Analysis and Review CAPA Management: Best Practices and FDA QSR Mandate Establishing a corrective and preventive
More informationPREPARING A CLIENT FOR INVESTIGATIONS
PREPARING A CLIENT FOR INVESTIGATIONS INVESTIGATIONS Investigations Can Involve: - Industry or Sector Wide Investigation - Targeting a Company or Group of Companies - Unannounced Inspections ( Dawn Raids
More informationSUPPLIERS AND SUBCONTRACTORS
Page: 1 of 8 SUPPLIERS AND ISSUE STATUS Issue Date: 11-04-2016 Issued for Use Revision Date: 30-01-2017 Revision No.: 1 Action Position Issued By: Reviewed By: Reviewed By: Approved By: QESH Document Controller
More informationQUALITY quality standard that the data are credible and the rights, safety, integrity and confidentiality of the subjects are protected HOW???
L.Massad GCP an International Ethical and Scientific quality standard by which clinical trials are designed, implemented and reported so that there is public assurance that the data are credible and the
More informationGIRP-IPF Study 2016 KEY FINDINGS EUROPEAN HEALTHCARE DISTRIBUTION ASSOCIATION GROUPEMENT INTERNATIONAL DE LA RÉPARTITION PHARMACEUTIQUE
GIRP-IPF Study 2016 KEY FINDINGS EUROPEAN HEALTHCARE DISTRIBUTION ASSOCIATION GROUPEMENT INTERNATIONAL DE LA RÉPARTITION PHARMACEUTIQUE The role of the pharmaceutical wholesale sector 2 ROLE OF PHARMACEUTICAL
More informationGood Distribution Practices Toolkit. Quality Management System 08 March 2016
Good Distribution Practices Toolkit Quality Management System 08 March 2016 1 Quality Policy GDP, Legal, Environmental, H&S Processes & Systems Resources Risk Assessments 2 Quality Policy & Objectives
More informationPrequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer
Part 1: General information Name of Manufacturer Production Block Physical address Contact address Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer. Clean Utilities in the Basement.
More informationAnnex 4. Guidance on good manufacturing practices: inspection report. Background
Annex 4 Guidance on good manufacturing practices: inspection report Background The need for revision of the Guidance on good manufacturing practices: inspection report (World Health Organization (WHO)
More informationCurrent Global GMP Status and Trends With Focus on EU & PIC/S JPMA Annual Meeting, Tokyo & Osaka, September 2012 Dr.-Ing.
Current Global GMP Status and Trends With Focus on EU & PIC/S JPMA Annual Meeting, Tokyo & Osaka, September 2012 Dr.-Ing. Stephan Rönninger Pharma Medicines Technical Operations Global Quality & Compliance,
More informationWHO Prequalification Team (WHO-PQT) Introduction to medicines inspections technical updates
Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers of diagnostic products, vaccines, finished pharmaceutical products and active pharmaceutical ingredients WHO Prequalification Team (WHO-PQT)
More informationEuropean Union (EU) Regulatory Trends in GMP. Clive Brading Tianjin, China September 23, 2009
European Union (EU) Regulatory Trends in GMP Clive Brading Tianjin, China September 23, 2009 -2- Presentation Topics EU Background Inspections outside the EU EMEA Inspection Outcomes Dedicated Facilities
More informationOursourcing and Supplier Qualification from the perspective of the pharmaceutical Industry
Oursourcing and Supplier Qualification from the perspective of the pharmaceutical Industry 1 Presentation Outline Pharmaceutical Quality Management Partner Selection and Qualification Shipping Qualification
More informationEURASIAN ECONOMIC COMMISSION COUNCIL
EURASIAN ECONOMIC COMMISSION COUNCIL Working translation: DECISION October 9, 2014 No.94 Minsk On the Regulation on the Harmonized Procedure of Joint On-Site Inspections and of Taking Samples of Goods
More informationNew Data Integrity Regulations and Practical Advice for Life Science Laboratories. we prove it.
1 How to Meet New MHRA, FDA, EMA and WHO Data Integrity Guidelines white paper New Data Integrity Regulations and Practical Advice for Life Science Laboratories we prove it. 2 How to Avoid Poor Temperature
More informationPrequalification of Medicines Programme
Prequalification of Medicines Programme SOP 408.4 Annex A WHO PUBLIC INSPECTION REPORT Finished Product Manufacturer WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: General
More informationQuality and GMP Compliance for Virtual Companies (Pharmaceutical, Medical Device & Biologics Industries)
Quality and GMP Compliance for Virtual Companies (Pharmaceutical, Medical Device & Biologics Industries) *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! Today, many companies operate
More informationTaking a Leap Toward Global Supply Chain Efficiency - Part II
Taking a Leap Toward Global Supply Chain Efficiency - Part II 2 Supply Chain Brochure - Part II INTRODUCTION Pharmaceutical manufacturers face a number of challenges in the production and delivery of medicinal
More informationGMP Track 1 Day 2 Session 1 Vendor Assurance
GMP Track 1 Day 2 Session 1 Vendor Assurance 11 August 2015 150403_POUT This session Three presentations Chapter 6 and 7 - Trevor Schoerie Quality Control Out sourced Activities Draft - FDA Quality Metrics
More informationRegulatory Requirements & Recent Changes, including expectations for APIs & IMPs
Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs Neil Raw - GMP Inspector Richard Andrews - Operations Manager 11 th November 2008 Programme: Regulatory Requirements Neil
More informationSection 3 Company Organisation and Certification Procedures
OF&G ORGANIC STANDARDS AND CERTIFICATION MANUAL 3.0 Contents Page The describe how the company is structured and administered, and explains the certification procedures, the complaints procedures and the
More informationGMP Inspection Process. Types of GMP Inspection. Module 18 Slide 1 of 14 WHO - EDM
GMP Inspection Process Types of GMP Inspection Module 18 Slide 1 of 14 WHO - EDM Objectives 1. To review the different types of inspection 2. To examine when each is appropriate 3. To discuss inspections
More information18.H Questionnaire for preparing GMP-inspections
Questionnaire for preparing -inspections Questionnaire for preparing -inspections Here you will find answers to the following questions: What questions are typically asked during inspections based on current
More informationABSTRACT INTERNATIONAL LOGISTICS CRITERIA ON MEDICINAL PRODUCTS FOR HUMAN USE 1. INTRODUCTION. Shiang-Min Meng 1+ Hsiu-Yun Yang 2 Jane Dai 3
International Journal of Asian Social Science ISSN(e): 2224-4441 ISSN(p): 2226-5139 DOI: 10.18488/journal.1.2019.92.148.168 Vol. 9, No. 2, 148-168 URL: www.aessweb.com INTERNATIONAL LOGISTICS CRITERIA
More informationLeading Practices on Compliance Series: Design History File (DHF): Tips for Creating a Successful DHF Tuesday, November 27, :00 1:00 pm Eastern
Leading Practices on Compliance Series: (DHF): Tips for Creating a Successful DHF Tuesday, November 27, 2012 12:00 1:00 pm Eastern Jack Ward, Senior Director Myraqa, Inc. Leading Practices on Compliance
More informationJournal of Chemical and Pharmaceutical Research
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research ISSN No: 0975-7384 CODEN(USA): JCPRC5 J. Chem. Pharm. Res., 2011, 3(6):88-98 Conduct of Inspections for Pharmaceutical Manufactures
More informationDATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS
GLOBAL PROVIDER, LOCAL SOLUTIONS IN YOUR LANGUAGE DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS Francesco Amorosi PhD Octorber 2017 DATA INTEGRITY & CSV:
More informationHow to Survive an EBAA Site Inspection
How to Survive an EBAA Site Inspection Woodford S. Van Meter,MD Lexington, KY EBAA Site Inspections: Scheduled by Accreditation Board Approximately 15-20 eyebanks inspected every six months Individual
More informationApplying a Knowledge-Based Approach to Pharmaceutical Supply Chain Temperature Control Management
May 1-3, 2012 Javits Center New York, NY Applying a Knowledge-Based Approach to Pharmaceutical Supply Chain Control Management Arminda O. Montero Program Manager, Distribution QA Global Pharmaceutical
More informationCould Poor Temperature Data Management be Putting Your GxP Facility at Risk for Data Integrity Violations? we prove it.
1 How to Meet New MHRA, FDA and WHO Data Integrity Guidelines WHITE PAPER Could Poor Temperature Data Management be Putting Your GxP Facility at Risk for Data Integrity Violations? we prove it. 2 How to
More informationAddressing Key FDA Citations with Training. Align UL EduNeering Courses to Top FDA Warning Letter Topics
Addressing Key FDA Citations with Training Align UL EduNeering Courses to Top FDA Warning Letter Topics Addressing Key FDA Citations with Training Align UL EduNeering Courses to Top FDA Warning Letter
More informationAUDIT REPORT. Audit of Offi cial Controls carried out by the Local Authority Veterinary Service Cavan County Council
AUDIT REPORT Audit of Offi cial Controls carried out by the Local Authority Veterinary Service AUDIT REPORT Audit of Official Controls carried out by the Local Authority Veterinary Service TABLE OF CONTENTS
More informationOutsourcing - managing risks and opportunities over which you now have less control
Outsourcing - managing risks and opportunities over which you now have less control Kevin O Donnell, PhD PDA Meeting, Dublin 22 nd November 2018 Slide 2 Typical Examples The key GMP Requirements & Guidance
More informationGuide to Good Distribution Practice of Medicinal Products for Human Use
Guide to Good Distribution Practice of Medicinal Products for Human Use IA-G0046-3 9 NOVEMBER 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes
More informationConducting and reporting a GCP Inspection. Gunnar Danielsson Medical Products Agency
Conducting and reporting a GCP Inspection Gunnar Danielsson Medical Products Agency Preparation for an inspection Inspection plan Create worksheets for the inspection general project specific study specific
More informationPrequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Tablets
Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: information about the inspection Name of manufacturer Physical address production departments
More informationEKOTAR Programme Manual Organic Production Instruction Contracting
Page 1 / 6 Contracting, registration and resignation of a client 1. Scope and aim This document is additional to the General Program manual and describes in detail how to act from the first contact with
More informationComputer System Validation - Reduce Costs and Avoid 483s
Computer System Validation - Reduce Costs and Avoid 483s *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! This Computer System Validation Training course will explore proven techniques
More informationGuide to Quality System for General Sale Wholesale Distributors
Guide to Quality System for General Sale Wholesale Distributors IA-G0038-5 20 DECEMBER 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only.
More informationEffective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)
Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs) *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! The globalization of the pharmaceutical
More informationEmbracing a Culture of Self Correction
Embracing a Culture of Self Correction Making the Most of Internal Audit Programs Julie Larsen Principal, BioTeknica Where I have been ASCP Certified Medical Technologist Introduction Rush St. Luke s Presbyterian
More information2012 Academy Seminar - Thessaloniki, Greece Storage and transportation of pharmacy compounded drugs
2012 Academy Seminar - Thessaloniki, Greece Storage and transportation of pharmacy compounded drugs 21 April 2012, Barbara Wimmer, barbara.wimmer@gespag.at Conflict of interest: nothing to disclose 1.
More informationSummary of differences between Bonsucro/Bonsucro EU RED mass balance CoC standard and Draft of revised Bonsucro CoC standard 16 October 2018
Summary of differences between Bonsucro/Bonsucro EU RED mass balance CoC standard and Draft of revised Bonsucro CoC standard Title: Bonsucro chain of custody standard Title: Bonsucro/Bonsucro EU RED mass
More informationNew GMPs for Active Substances & Excipients. Presented by Eoin Hanley 4 July, 2016
New GMPs for Active Substances & Excipients Presented by Eoin Hanley 4 July, 2016 What we will cover in this session The changing landscape EC Guideline on principles of GDP of active substances Formalised
More informationSupplier Questionnaire and On-site Supplier Evaluation
Supplier Questionnaire and On-site Supplier Evaluation GENERAL EVALUATION INSTRUCTIONS Purpose Application This On-site Supplier Evaluation (OSE) is to assess the supplier's ability to produce a quality
More informationThe Impact of Quality Culture on Quality Risk Management. FDA Perspective on Quality Culture; how it Impacts Risk Management
The Impact of Quality Culture on Quality Risk Management FDA Perspective on Quality Culture; how it Impacts Risk Management Teresa Gorecki Practice Lead Compliance Architects Agenda The WHAT Definitions
More informationISCC Integrity Program
ISCC PLUS 254 Integrity Program ISCC Integrity Program ISCC PLUS 254 V 1.0 Copyright notice ISCC 2012 This ISCC document is protected by copyright. It is freely available from the ISCC website or upon
More informationCLICK TO ADD TITLE [SPEAKERS NAMES]
CLICK TO ADD TITLE [SPEAKERS NAMES] [DATE] Thanks to our generous sponsors Increasing access to essential medicines through pre-qualified, quality local sources Stephen Kimatu Partnership for Supply Chain
More informationPHARMACY, MEDICINES & POISONS BOARD GUIDELINES FOR RECALL OF MEDICINES AND HEALTH PRODUCTS IN MALAWI
PHARMACY, MEDICINES & POISONS BOARD GUIDELINES FOR RECALL OF MEDICINES AND HEALTH PRODUCTS IN MALAWI Draft September 2015 1. INTRODUCTION The Malawi Pharmacy Medicines and Poisons Board (PMPB) was established
More informationQuality Systems and GMPin Pharmaceutical Manufacturing. Marleine Akl Quality Assurance Algorithm SAL
Session s Outline 1. Bio-equivalence 2. A 30-minute DVD on GMP Break 3. Quality Systems and GMPs in Pharmaceutical Manufacturing 4. Good Distribution Practices 5. Questionnaire (could not go through due
More informationSelf-Inspection and its potential benefits via ICH Q9 & Q10
Self-Inspection and its potential benefits via ICH Q9 & Q10 Kevin O Donnell, Ph.D. Senior Inspector & Market Compliance Manager Irish Medicines Board IMB Information Day October 23 rd, 2008 Slide 1 Topics
More informationThe FDA Just Arrived... Are You Ready? Presented By Sandra Lueken Sr. Director, Quality AstraZeneca Biologics
The FDA Just Arrived... Are You Ready? Presented By Sandra Lueken Sr. Director, Quality AstraZeneca Biologics Objectives Review Quality Systems Audit Approach and cgmp fundamentals Logistical Audit Preparation
More informationSupplier Qualification and Regulatory Compliance in International Biopharm Logistics. November 19 th, Copenhagen, 2015
Supplier Qualification and Regulatory Compliance in International Biopharm Logistics November 19 th, Copenhagen, 2015 Pharmaceutical Quality Management Partner Selection and Qualification Outsourcing and
More informationWhite paper Audits in automated production
White paper Audits in automated production data management for automation Introduction: Audits in automated production In the field of production management, audits have become an important tool for analysing
More informationAUDIT REPORT. Audit of Offi cial Controls carried out by the Local Authority Veterinary Service Louth County Council
AUDIT REPORT Audit of Offi cial Controls carried out by the Local Authority Veterinary Service AUDIT REPORT Audit of Official Controls carried out by the Local Authority Veterinary Service TABLE OF CONTENTS
More informationUPPLIER ANUAL. Issued: 01 Aug 13
UPPLIER ANUAL Issued: 01 Aug 13 Table of Contents Our Company 3 Our Vision 3 Scope and Purpose 4 Responsibilities 4 General Expectations and Requirements 5 Supplier Quality Management System 6 Supplier
More informationYour Partner Of Choice For Global Pharma Compliance. Corporate Presentation
Your Partner Of Choice For Global Pharma Compliance. Corporate Presentation Vision We aspire to be a partner of choice for global compliance & project management across the pharmaceutical value chain,
More informationReview of HPRA Draft Guide to Distribution of Medical Devices, including in vitro diagnostic Medical Devices
Review of HPRA Draft Guide to Distribution of Medical Devices, including in vitro diagnostic Medical Devices Ref: IA-G0004-x Summary DCC Vital welcomes the new draft guidance which will provide clarity
More information